Is lymph-node micrometastasis in gallbladder cancer a significant prognostic factor?

Hepatogastroenterology. 2012 Jan-Feb;59(113):31-5. doi: 10.5754/hge10010.

Abstract

Background/aims: The purpose of our study was to investigate prognostic significance of lymph-node micrometastasis in gallbladder carcinoma.

Methodology: In total, 1,094 lymph nodes from 41 patients who had undergone radical resection with lymph-node dissection, including para-aortic lymph nodes were stained with hematoxylin and eosin (H&E) and immunostained with anti-cytokeratin 7/8 antibody. Micrometastasis in each lymph node was defined as tumor cells that were detectable only by immunohistochemical evaluation and were not detected by H&E staining.

Results: Metastases were detected in 163 lymph nodes (14.9%) by H&E staining. Micrometastases were found in 25 of the remaining lymph nodes (2.3%). Among 24 patients with lymph node metastasis based on the H&E staining, 12 had micrometastases. Of the 17 patients in whom lymph-node metastasis was not detected by the H&E staining, one was found to have micrometastasis. Micrometastasis correlated significantly with lymph node metastasis on H&E staining and pN (Tumor-Node-Metastasis 5th ed.). On multivariate analysis of data from 17 node-positive patients who underwent curative resection, micrometastasis and microscopic venous invasion were significant prognostic factors.

Conclusions: Our findings suggest that micrometastasis might be traces of scatter of cancer cells to the whole body rather than an event in an initial stage of the metastasis.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Carcinoma / mortality
  • Carcinoma / secondary*
  • Carcinoma / surgery
  • Female
  • Gallbladder Neoplasms / mortality
  • Gallbladder Neoplasms / pathology*
  • Gallbladder Neoplasms / surgery
  • Humans
  • Immunohistochemistry
  • Japan
  • Kaplan-Meier Estimate
  • Lymph Node Excision
  • Lymph Nodes / pathology*
  • Lymph Nodes / surgery
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Neoplasm Micrometastasis
  • Neoplasm Staging
  • Predictive Value of Tests
  • Proportional Hazards Models
  • Risk Assessment
  • Risk Factors
  • Staining and Labeling
  • Survival Rate
  • Time Factors
  • Treatment Outcome